Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET

Company Participants

Matt Hall – Director, Corporate Development and IR
Cheryl Blanchard – President and CEO
Steve Griffin – EVP, CFO and Treasurer

Conference Call Participants

Jim Sidoti – Sidoti & Co.
Mike Petusky – Barrington Research

Operator

Good morning, ladies and gentlemen, and welcome to Anika’s Third Quarter Earnings Conference Call. [Operator Instructions]. I would like to remind everyone that this call is being recorded on Thursday, October 31, 2024.

I will now turn the call over to Matt Hall, Director, Corporate Development and Investor Relations. Please proceed.

Matt Hall

Thank you. Good morning, and thank you for joining us for Anika’s third quarter 2024 conference call and webcast. I’m Matt Hall, Anika’s Director of Corporate Development and Investor Relations. I joined Anika 2.5 years ago in Business Development and have recently taken over Investor Relations responsibilities from Mark, who exited the company earlier this quarter. I have spent more than 15 years in the healthcare and life sciences investment space, and I look forward to engaging with our investors and analysts on the call today.

Our Q3 earnings press release was issued earlier this morning and is available on our Investor Relations website located at www.anika.com as are the supplementary PowerPoint slides that will be used for the discussion today.

With me on the call today are Dr. Cheryl Blanchard, President and Chief Executive Officer; and Steve Griffin, Executive Vice President, Chief Financial Officer and Treasurer.

Please take a moment and open the slide presentation and refer to Slide 2. Before we begin, please understand that certain statements made during the call today constitute forward-looking statements as defined in the Securities Exchange Act of 1934. These statements are based on our current beliefs and expectations and